About the journal
Cardiovascular Research is the international journal of the European Society of Cardiology for basic and translational research, spanning all topics within cardiology and cardiovascular biology. The journal aims to enhance insight into cardiovascular disease mechanisms and the prospects for innovation. The journal welcomes submission of papers both at the molecular, sub-cellular, cellular, organ, and organism level, and of clinical proof-of-concept and translational studies. Manuscripts are expected to provide a significant contribution to the field with relevance for cardiovascular biology and diseases.
Publishing with Cardiovascular Research
Publishing with Cardiovascular Research enables authors to align themselves and their work with the journal’s strong scientific standing, and to benefit from:
- efficient decisions on your paper
- rigorous, constructive reviews from editors and peers
- swift production process and online publication
- no charges for colour figures
- the journal’s global readership, with over 2 million downloads per year
- promotion of your research to OUP and the ESC’s combined social media following of 80,000 followers (and counting!)
Cardiovascular Research is proud of its fast Reviewing and Editorial Decision system. Manuscripts are normally evaluated by three members from an international panel of reviewers and, in most cases, we provide a first editorial decision within 22 days of receipt.
Manuscripts may be submitted as Original Articles, Rapid Communications, or Reviews. The journal also publishes Letters to the Editor, Editorials, and comprehensive series of reviews as Spotlight Issues.
Audience
Scientists in the cardiovascular field, cardiologists and related specialists in research and clinical medicine.
Impact Factor and ranking
| Year | Impact Factor | SI: Cardiac & Cardiovascular Systems |
|---|---|---|
| 2022 | 10.9 | 12 out of 143 |
| 2021 | 14.239 | 10 out of 143 |
| 2020 | 10.787 | 12 out of 142 |
| 2019 | 8.168 | 12 out of 138 |
| 2018 | 7.014 | 12 out of 136 |
| 2017 | 6.290 | 16 out of 128 |
| 2016 | 5.878 | 19 out of 126 |
| 2015 | 5.465 | 16 out of 124 |
| 2014 | 5.940 | 11 out of 123 |
| 2013 | 5.808 | 15 out of 125 |
| 2012 | 5.940 | 12 out of 122 |
| 2011 | 6.064 | 13 out of 117 |
| 2010 | 6.051 | 9 out of 114 |
| 2009 | 5.801 | 8 out of 95 |
| 2008 | 5.947 | 6 out of 78 |
| 2007 | 6.127 | 5 out of 74 |
| 2006 | 5.826 | 5 out of 74 |
| 2005 | 5 out of 72 | |
| 2004 | 6 out of 71 | |
| 2003 | 5 out of 70 |
This information is taken from the Journal Citation Reports™ (Clarivate, 2023), published annually as part of the Science Citation Index by the Web of Science Group.
Publication Ethics and Malpractice Statement
Cardiovascular Research and Oxford University Press are members of the Committee on Publication Ethics (COPE). The journal also subscribes to the International Committee of Medical Journal Editors (ICJME) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly work in Medical Journals. The journal expects all parties involved in the publication of content in Cardiovascular Research (the publisher, editors, authors, and reviewers) to follow these guidelines on best practice and publication ethics. The Editors are further supported by the ESC Journal Family Ethics Committee.
